Shares of Bausch Health, formerly known as Valeant, rise 3% on FDA approval for psoriasis treatment
April 25, 2019 at 13:32 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|